So Sugita, Kotone Hata, Naoki Takamatsu, Kentaro Kimura, Lecsy Gonzalez, Krandhasi Kodaiarasu, Christian Miller, Ikue Umemoto, Keitaro Murayama, Tomohiro Nakao, et al. Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol. BMJ open. 2023. 13. 3. e069386
The clinical characterization of the adult patient with depression aimed at personalization of management
https://www.jspn.or.jp/modules/activity/index.php?content_id=313 2020
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics
https://www.jspn.or.jp/modules/activity/index.php?content_id=285 2020
The revised German evidence- and consensus-based schizophrenia guideline
https://www.jspn.or.jp/modules/activity/index.php?content_id=285 2020
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
https://www.jspn.or.jp/modules/activity/index.php?content_id=285 2020
Perspectives on Post-COVID-19 Conditions Management and Future Directions - Insights from longitudinal data in a national patient database in Japan
(Asian Cognitive Behavioral Therapies Association, 8th Asian CBT Congress 2024)
Understanding neuropsychiatric symptoms and their relevant context in post-COVID-19 condition: Implications for the development of cognitive-behavior therapy
(Asian Cognitive Behavioral Therapies Association, 8th Asian CBT Congress. 2024)